| Dr Usha A Mehta, MD | |
|
2050 Claire Ct, Glenview, IL 60025-7635 | |
| (847) 467-7423 | |
| (847) 556-1715 |
| Full Name | Dr Usha A Mehta |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Hospice And Palliative Medicine |
| Location | 2050 Claire Ct, Glenview, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114280682 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0002X | Internal Medicine - Hospice And Palliative Medicine | 036046244 (Illinois) | Primary |
| Entity Name | Midwest Palliative & Hospice Carecenter |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457335838 PECOS PAC ID: 5799678975 Enrollment ID: O20040213000044 |
News Archive
AXT are proud to announce that they have recently been appointed the exclusive Australian and New Zealand distributor for Oxford Nanoimaging (ONI). ONI is a UK-based company that has commercialised the "Nanoimager" a revolutionary super-resolution fluorescence microscope capable of single molecule imaging.
"Food security concerns as the world's population surpasses seven billion have prompted global companies to become more actively involved in ensuring future supplies, participants at an agricultural conference said on Monday," Reuters reports.
Malaria has been one of the world's biggest killers for as long as records have been kept. With resistance to existing antimalarial drugs on the rise, there is a renewed push to find different ways to fight it. Two University of Houston (UH) engineers have stepped up to the plate to answer the call.
Cook Medical has submitted its Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the company's unique polymer-free Zilver® PTX® Drug-Eluting Peripheral Stent. Intended for use in patients with peripheral arterial disease (PAD) in the superficial femoral artery (SFA), Zilver PTX is a self-expanding, highly durable nitinol stent that uses a proprietary, polymer-free technology to deliver a locally therapeutic dose of paclitaxel, an antiproliferative drug, to the target lesion.
A team of University of British Columbia researchers has identified fat-producing cells that possess "dual-personalities" and may further the development of treatments for muscle diseases such as muscular dystrophy and fibrosis.
› Verified 5 days ago
| Entity Name | Journeycare, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154324994 PECOS PAC ID: 2062578305 Enrollment ID: O20090512000566 |
News Archive
AXT are proud to announce that they have recently been appointed the exclusive Australian and New Zealand distributor for Oxford Nanoimaging (ONI). ONI is a UK-based company that has commercialised the "Nanoimager" a revolutionary super-resolution fluorescence microscope capable of single molecule imaging.
"Food security concerns as the world's population surpasses seven billion have prompted global companies to become more actively involved in ensuring future supplies, participants at an agricultural conference said on Monday," Reuters reports.
Malaria has been one of the world's biggest killers for as long as records have been kept. With resistance to existing antimalarial drugs on the rise, there is a renewed push to find different ways to fight it. Two University of Houston (UH) engineers have stepped up to the plate to answer the call.
Cook Medical has submitted its Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the company's unique polymer-free Zilver® PTX® Drug-Eluting Peripheral Stent. Intended for use in patients with peripheral arterial disease (PAD) in the superficial femoral artery (SFA), Zilver PTX is a self-expanding, highly durable nitinol stent that uses a proprietary, polymer-free technology to deliver a locally therapeutic dose of paclitaxel, an antiproliferative drug, to the target lesion.
A team of University of British Columbia researchers has identified fat-producing cells that possess "dual-personalities" and may further the development of treatments for muscle diseases such as muscular dystrophy and fibrosis.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Usha A Mehta, MD 2050 Claire Ct, Glenview, IL 60025-7635 Ph: (847) 467-7423 | Dr Usha A Mehta, MD 2050 Claire Ct, Glenview, IL 60025-7635 Ph: (847) 467-7423 |
News Archive
AXT are proud to announce that they have recently been appointed the exclusive Australian and New Zealand distributor for Oxford Nanoimaging (ONI). ONI is a UK-based company that has commercialised the "Nanoimager" a revolutionary super-resolution fluorescence microscope capable of single molecule imaging.
"Food security concerns as the world's population surpasses seven billion have prompted global companies to become more actively involved in ensuring future supplies, participants at an agricultural conference said on Monday," Reuters reports.
Malaria has been one of the world's biggest killers for as long as records have been kept. With resistance to existing antimalarial drugs on the rise, there is a renewed push to find different ways to fight it. Two University of Houston (UH) engineers have stepped up to the plate to answer the call.
Cook Medical has submitted its Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the company's unique polymer-free Zilver® PTX® Drug-Eluting Peripheral Stent. Intended for use in patients with peripheral arterial disease (PAD) in the superficial femoral artery (SFA), Zilver PTX is a self-expanding, highly durable nitinol stent that uses a proprietary, polymer-free technology to deliver a locally therapeutic dose of paclitaxel, an antiproliferative drug, to the target lesion.
A team of University of British Columbia researchers has identified fat-producing cells that possess "dual-personalities" and may further the development of treatments for muscle diseases such as muscular dystrophy and fibrosis.
› Verified 5 days ago
Karen Chiu, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2100 Pfingsten Rd Ste 3001a, Glenview, IL 60026 Phone: 847-657-5840 Fax: 847-657-5732 | |
Lynn K. Martin, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 2550 Waukegan Rd, Suite 100, Glenview, IL 60025 Phone: 847-729-2541 Fax: 847-729-2546 | |
Dr. Jamee Castillo Tantoco, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2050 Pfingsten Rd Ste 320, Glenview, IL 60026 Phone: 847-998-4170 Fax: 847-998-4165 | |
Dr. Gregory Aaron Wallman, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2501 Compass Rd, Suite 100, Glenview, IL 60026 Phone: 847-901-5200 Fax: 847-904-4907 | |
Rebecca Wanting Tsang, M.D., M.P.H. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2150 Pfingsten Rd Ste 3000, Glenview, IL 60026 Phone: 847-657-1900 | |
Dr. Monica S. Borkar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2100 Pfingsten Rd, Suite B230, Glenview, IL 60026 Phone: 847-657-1900 Fax: 847-657-1961 | |
Joel R. Green, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2100 Pfingsten Rd Ste 3001a, Glenview, IL 60026 Phone: 847-657-5840 Fax: 847-657-5835 |